Search

everythinglearnresearchcommunity

for

Search:↓

The N-K GM Series offers treatments for full hair restoration and permanent hair removal, claiming 100% effectiveness without side effects.

The N-K GM Series offers treatments for full hair restoration and permanent hair removal, claiming 100% effectiveness without side effects.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose can help treat hair loss by reducing certain hormones and promoting hair growth.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

PCOS may increase the risk of mental health issues like depression and anxiety.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Combining different drugs can improve hair loss treatment.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.